EFPIA：2026年创新药物不可用和获取延迟的根本原因_缩短等待时间报告（英文版）

The unprecedented speed of innovation exhibited over the last five years and the promise of the industry pipeline2 provide an important opportunity to improve outcomes for patients. There is common agreement that the value of innovation is realised only when patients benefit from advances in treatment. However, a significant number of medicines are not available across all European Union (EU) markets. 3